2024-10-012025-09-302025-09-30false12225386CERVEAU DIAGNOSTICS LIMITED2026-01-2086101falseiso4217:GBPxbrli:pure122253862024-09-30122253862025-09-30122253862024-10-012025-09-30122253862023-09-30122253862024-09-30122253862023-10-012024-09-3012225386bus:SmallEntities2024-10-012025-09-3012225386bus:AuditExempt-NoAccountantsReport2024-10-012025-09-3012225386bus:FullAccounts2024-10-012025-09-3012225386bus:PrivateLimitedCompanyLtd2024-10-012025-09-3012225386core:WithinOneYear2025-09-3012225386core:AfterOneYear2025-09-3012225386core:WithinOneYear2024-09-3012225386core:AfterOneYear2024-09-3012225386core:ShareCapital2025-09-3012225386core:SharePremium2025-09-3012225386core:RevaluationReserve2025-09-3012225386core:OtherReservesSubtotal2025-09-3012225386core:RetainedEarningsAccumulatedLosses2025-09-3012225386core:ShareCapital2024-09-3012225386core:SharePremium2024-09-3012225386core:RevaluationReserve2024-09-3012225386core:OtherReservesSubtotal2024-09-3012225386core:RetainedEarningsAccumulatedLosses2024-09-3012225386core:LandBuildings2025-09-3012225386core:PlantMachinery2025-09-3012225386core:Vehicles2025-09-3012225386core:FurnitureFittings2025-09-3012225386core:OfficeEquipment2025-09-3012225386core:NetGoodwill2025-09-3012225386core:IntangibleAssetsOtherThanGoodwill2025-09-3012225386core:ListedExchangeTraded2025-09-3012225386core:UnlistedNon-exchangeTraded2025-09-3012225386core:LandBuildings2024-09-3012225386core:PlantMachinery2024-09-3012225386core:Vehicles2024-09-3012225386core:FurnitureFittings2024-09-3012225386core:OfficeEquipment2024-09-3012225386core:NetGoodwill2024-09-3012225386core:IntangibleAssetsOtherThanGoodwill2024-09-3012225386core:ListedExchangeTraded2024-09-3012225386core:UnlistedNon-exchangeTraded2024-09-3012225386core:LandBuildings2024-10-012025-09-3012225386core:PlantMachinery2024-10-012025-09-3012225386core:Vehicles2024-10-012025-09-3012225386core:FurnitureFittings2024-10-012025-09-3012225386core:OfficeEquipment2024-10-012025-09-3012225386core:NetGoodwill2024-10-012025-09-3012225386core:IntangibleAssetsOtherThanGoodwill2024-10-012025-09-3012225386core:ListedExchangeTraded2024-10-012025-09-3012225386core:UnlistedNon-exchangeTraded2024-10-012025-09-3012225386core:MoreThanFiveYears2024-10-012025-09-3012225386core:Non-currentFinancialInstruments2025-09-3012225386core:Non-currentFinancialInstruments2024-09-3012225386dpl:CostSales2024-10-012025-09-3012225386dpl:DistributionCosts2024-10-012025-09-3012225386core:LandBuildings2024-10-012025-09-3012225386core:PlantMachinery2024-10-012025-09-3012225386core:Vehicles2024-10-012025-09-3012225386core:FurnitureFittings2024-10-012025-09-3012225386core:OfficeEquipment2024-10-012025-09-3012225386dpl:AdministrativeExpenses2024-10-012025-09-3012225386core:NetGoodwill2024-10-012025-09-3012225386core:IntangibleAssetsOtherThanGoodwill2024-10-012025-09-3012225386dpl:GroupUndertakings2024-10-012025-09-3012225386dpl:ParticipatingInterests2024-10-012025-09-3012225386dpl:GroupUndertakingscore:ListedExchangeTraded2024-10-012025-09-3012225386core:ListedExchangeTraded2024-10-012025-09-3012225386dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-10-012025-09-3012225386core:UnlistedNon-exchangeTraded2024-10-012025-09-3012225386dpl:CostSales2023-10-012024-09-3012225386dpl:DistributionCosts2023-10-012024-09-3012225386core:LandBuildings2023-10-012024-09-3012225386core:PlantMachinery2023-10-012024-09-3012225386core:Vehicles2023-10-012024-09-3012225386core:FurnitureFittings2023-10-012024-09-3012225386core:OfficeEquipment2023-10-012024-09-3012225386dpl:AdministrativeExpenses2023-10-012024-09-3012225386core:NetGoodwill2023-10-012024-09-3012225386core:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3012225386dpl:GroupUndertakings2023-10-012024-09-3012225386dpl:ParticipatingInterests2023-10-012024-09-3012225386dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-012024-09-3012225386core:ListedExchangeTraded2023-10-012024-09-3012225386dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-012024-09-3012225386core:UnlistedNon-exchangeTraded2023-10-012024-09-3012225386core:NetGoodwill2025-09-3012225386core:IntangibleAssetsOtherThanGoodwill2025-09-3012225386core:LandBuildings2025-09-3012225386core:PlantMachinery2025-09-3012225386core:Vehicles2025-09-3012225386core:FurnitureFittings2025-09-3012225386core:OfficeEquipment2025-09-3012225386core:AfterOneYear2025-09-3012225386core:WithinOneYear2025-09-3012225386core:ListedExchangeTraded2025-09-3012225386core:UnlistedNon-exchangeTraded2025-09-3012225386core:ShareCapital2025-09-3012225386core:SharePremium2025-09-3012225386core:RevaluationReserve2025-09-3012225386core:OtherReservesSubtotal2025-09-3012225386core:RetainedEarningsAccumulatedLosses2025-09-3012225386core:NetGoodwill2024-09-3012225386core:IntangibleAssetsOtherThanGoodwill2024-09-3012225386core:LandBuildings2024-09-3012225386core:PlantMachinery2024-09-3012225386core:Vehicles2024-09-3012225386core:FurnitureFittings2024-09-3012225386core:OfficeEquipment2024-09-3012225386core:AfterOneYear2024-09-3012225386core:WithinOneYear2024-09-3012225386core:ListedExchangeTraded2024-09-3012225386core:UnlistedNon-exchangeTraded2024-09-3012225386core:ShareCapital2024-09-3012225386core:SharePremium2024-09-3012225386core:RevaluationReserve2024-09-3012225386core:OtherReservesSubtotal2024-09-3012225386core:RetainedEarningsAccumulatedLosses2024-09-3012225386core:NetGoodwill2023-09-3012225386core:IntangibleAssetsOtherThanGoodwill2023-09-3012225386core:LandBuildings2023-09-3012225386core:PlantMachinery2023-09-3012225386core:Vehicles2023-09-3012225386core:FurnitureFittings2023-09-3012225386core:OfficeEquipment2023-09-3012225386core:AfterOneYear2023-09-3012225386core:WithinOneYear2023-09-3012225386core:ListedExchangeTraded2023-09-3012225386core:UnlistedNon-exchangeTraded2023-09-3012225386core:ShareCapital2023-09-3012225386core:SharePremium2023-09-3012225386core:RevaluationReserve2023-09-3012225386core:OtherReservesSubtotal2023-09-3012225386core:RetainedEarningsAccumulatedLosses2023-09-3012225386core:AfterOneYear2024-10-012025-09-3012225386core:WithinOneYear2024-10-012025-09-3012225386core:Non-currentFinancialInstrumentscore:CostValuation2024-10-012025-09-3012225386core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-012025-09-3012225386core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-012025-09-3012225386core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-012025-09-3012225386core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-012025-09-3012225386core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-012025-09-3012225386core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-012025-09-3012225386core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-012025-09-3012225386core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-012025-09-3012225386core:Non-currentFinancialInstrumentscore:CostValuation2025-09-3012225386core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-09-3012225386core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-09-3012225386core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-09-3012225386core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-09-3012225386core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-09-3012225386core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-09-3012225386core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-09-3012225386core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-09-3012225386core:Non-currentFinancialInstrumentscore:CostValuation2024-09-3012225386core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-3012225386core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-3012225386core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-3012225386core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-3012225386core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-3012225386core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-3012225386core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-3012225386core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-3012225386bus:Director12024-10-012025-09-3012225386bus:Director22024-10-012025-09-30

CERVEAU DIAGNOSTICS LIMITED

Registered Number
12225386
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2025

CERVEAU DIAGNOSTICS LIMITED
Company Information
for the year from 1 October 2024 to 30 September 2025

Directors

Ibrahim Djoukhadar
Hiba Fatayer

Registered Address

531 Denby Dale Road West
Calder Grove
Wakefield
WF4 3ND

Registered Number

12225386 (England and Wales)
CERVEAU DIAGNOSTICS LIMITED
Balance Sheet as at
30 September 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets31,782-
1,782-
Current assets
Cash at bank and on hand300,888240,221
300,888240,221
Creditors amounts falling due within one year4(39,289)(45,521)
Net current assets (liabilities)261,599194,700
Total assets less current liabilities263,381194,700
Net assets263,381194,700
Capital and reserves
Called up share capital100100
Profit and loss account263,281194,600
Shareholders' funds263,381194,700
The financial statements were approved and authorised for issue by the Board of Directors on 20 January 2026, and are signed on its behalf by:
Ibrahim Djoukhadar
Director
Registered Company No. 12225386
CERVEAU DIAGNOSTICS LIMITED
Notes to the Financial Statements
for the year ended 30 September 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Office Equipment3
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions2,1612,161
At 30 September 252,1612,161
Depreciation and impairment
Charge for year379379
At 30 September 25379379
Net book value
At 30 September 251,7821,782
At 30 September 24--
4.Creditors: amounts due within one year

2025

2024

££
Taxation and social security29,65438,051
Other creditors7,3315,571
Accrued liabilities and deferred income2,3041,899
Total39,28945,521
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
5.Provisions for liabilities
Provisions are made where an event has taken place that gives the company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of going the amount of the obligation. Provisions are charged as an expense to the profit and loss account in the year that the company becomes aware of the obligation and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties. When payments are eventually made, they are charged to the provision carried in the balance sheet.